PerpEquities

Illumina, Inc. (ILMN) balance sheet

NASDAQ · Healthcare · Medical - Diagnostics & Research · 8,600 employees · CEO Jacob Thaysen

Price
$235.99 -18.64%
Market cap
$35.6B
Enterprise value
$36.6B
Last report
Q3 '26 filed 2026-10-30
Next report
2027-02-04

At the end of Q3 '26 Illumina, Inc. (ILMN) held $1.34B in cash and short-term investments against $2.23B of debt incl. leases. Total assets $6.81B, total liabilities $3.67B, shareholders' equity $3.15B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$1.05B$1.11B$920M$869M$1.13B$1.11B$934M$1.05B$1.42B$1.09B$1.04B$1.29B
Short-term investments$6M$7M$74M$70M$93M$124M$221M$228M$215M$66M$128M$48M
Receivables$752M$650M$657M$715M$751M$714M$716M$751M$854M$738M$764M$738M
Inventory$587M$584M$561M$574M$547M$537M$575M$590M$564M$611M$629M$667M
Other current assets$216M$170M$223M$129M$228M$185M$120M$124M$238M$234M$273M$293M
Current assets$2.61B$2.58B$2.46B$2.37B$2.75B$2.67B$2.64B$2.8B$3.29B$2.74B$2.83B$3.04B
Property, plant & equipment (net)$1.55B$1.51B$1.32B$1.29B$1.23B$1.19B$1.16B$1.13B$1.13B$1.13B$1.11B$1.09B
Long-term investments$196M$213M$217M$218M$227M$251M$293M$305M$338M$351M$0$0
Goodwill$2.55B$2.55B$1.08B$1.11B$1.11B$1.11B$1.11B$1.11B$1.11B$1.28B$1.28B$1.28B
Intangible assets$2.99B$2.94B$278M$305M$295M$278M$238M$225M$210M$430M$410M$391M
Deferred tax assets$0$0$632M$617M$567M$553M$534M$490M$454M$458M$439M$454M
Other non-current assets$217M$245M$97M$103M$121M$122M$107M$118M$111M$172M$576M$561M
Non-current assets$7.5B$7.46B$3.62B$3.64B$3.56B$3.51B$3.45B$3.38B$3.36B$3.82B$3.82B$3.78B
Total assets$10.1B$10B$6.08B$6.01B$6.3B$6.18B$6.09B$6.18B$6.64B$6.56B$6.65B$6.81B
Liabilities
Accounts payable$245M$201M$199M$191M$221M$207M$200M$218M$240M$218M$230M$241M
Accrued expenses$223M$670M$197M$237M$317M$198M$214M$232M$142M$203M$394M$915M
Short-term debt$86M$0$744M$73M$578M$577M$578M$1.08B$499M$499M$500M$85M
Taxes payable$79M$67M$177M$0$101M$80M$0$0$0$0$0$0
Deferred revenue$252M$248M$238M$235M$260M$256M$247M$234M$270M$269M$261M$0
Other current liabilities$685M$202M$582M$112M$70M$122M$147M$118M$249M$182M$10M-$85M
Current liabilities$1.57B$1.47B$2.21B$975M$1.55B$1.44B$1.46B$1.96B$1.59B$1.57B$1.58B$1.16B
Long-term debt$1.49B$1.49B$1.49B$1.99B$1.49B$1.49B$1.49B$994M$1.49B$1.49B$1.49B$1.79B
Lease obligations (non-current)$687M$700M$616M$613M$554M$539M$528M$506M$486M$475M$454M$439M
Deferred revenue (non-current)$77M$0$0$58M$67M$73M$77M$73M$0$0$0$69M
Other non-current liabilities$543M$642M$331M$255M$272M$271M$271M$261M$360M$352M$289M$214M
Non-current liabilities$2.8B$2.83B$2.44B$2.91B$2.38B$2.37B$2.37B$1.83B$2.34B$2.32B$2.23B$2.51B
Total liabilities$4.37B$4.31B$4.65B$3.89B$3.93B$3.81B$3.83B$3.8B$3.92B$3.88B$3.81B$3.67B
Equity
Common stock & paid-in capital$2M$2M$2M$2M$2M$2M$2M$2M$2M$2M$2M$2M
Retained earnings-$19M-$145M-$2.13B-$1.43B-$1.24B-$1.11B-$876M-$726M-$392M-$258M-$51M$169M
Accumulated other comprehensive income-$1M$12M$14M-$5M$22M$8M-$21M-$12M-$10M$1M$8M$8M
Shareholders' equity$5.75B$5.73B$1.44B$2.13B$2.37B$2.37B$2.26B$2.38B$2.72B$2.68B$2.84B$3.15B
Debt
Total debt (incl. leases)$2.26B$2.28B$2.92B$2.67B$2.62B$2.61B$2.6B$2.58B$2.55B$2.54B$2.53B$2.23B
Net debt (debt - cash)$1.21B$1.17B$2B$1.81B$1.5B$1.49B$1.66B$1.53B$1.14B$1.46B$1.49B$939M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-27, 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-28, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-29, 10-Q 2024-09-29

Data as of 2026-11-02